Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Colastar (also referred to as Collastar) is a multi-ingredient nutraceutical product line developed and marketed by Healthon Lifesciences. It is designed for the management of joint and musculoskeletal conditions, such as osteoarthritis and inflammatory joint disorders. The formulation typically includes a combination of natural anti-inflammatory agents and joint-supportive compounds, including Boswellia serrata extract (standardized for 3-O-acetyl-11-keto-beta-boswellic acid or AKBA), chondroitin sulfate, bromelain, and curcuminoids. These ingredients work synergistically to inhibit pro-inflammatory enzymes like 5-lipoxygenase (5-LOX) and cyclooxygenase-2 (COX-2), and to reduce the levels of inflammatory cytokines such as TNF-alpha and IL-1beta. The product is available in various formulations, including tablets and sachets, and is marketed as a branded generic in India.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Colastar.